financetom
Business
financetom
/
Business
/
Corteva beats first-quarter profit estimates on higher seed pricing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Corteva beats first-quarter profit estimates on higher seed pricing
May 26, 2025 3:06 AM

(Reuters) - U.S. agrichemicals firm Corteva ( CTVA ) beat Wall Street expectations for first-quarter profit on Wednesday, helped by higher prices for its seeds.

The results come as the agrichemical industry braces itself against a potential fallout from U.S. President Donald Trump's trade policy, which have upended global supply chains.

Corteva ( CTVA ) said it continues to expect current-year net sales of $17.2 billion to $17.6 billion, but added the outlook did not reflect the impact of tariffs.

"We are not expecting a material net impact on our full-year 2025 results given policies in place today. Global grain and oilseed demand is not expected to decline, regardless of any changes in trade flows," it added.

In the seed segment, Corteva ( CTVA ) said prices rose 3% in most regions, led by North America. The segment reported a core profit of $842 million in the quarter, up 13% from last year.

However, total sales fell 2% to $4.42 billion during the first quarter due to weakness in key markets such as Europe, Latin America and Asia.

The Indianapolis-based company posted an adjusted operating profit of $1.13 per share for the three months ended March 31, compared with the analysts' estimate of 88 cents per share, according to data compiled by LSEG.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Stoke Therapeutics Insider Sold Shares Worth $313,038, According to a Recent SEC Filing
Stoke Therapeutics Insider Sold Shares Worth $313,038, According to a Recent SEC Filing
Mar 24, 2026
04:28 PM EDT, 03/24/2026 (MT Newswires) -- Jonathan Allan, General Counsel and Corporate Secretary, on March 20, 2026, sold 9,293 shares in Stoke Therapeutics ( STOK ) for $313,038. Following the Form 4 filing with the SEC, Allan has control over a total of 19,543 common shares of the company, with 19,543 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1623526/000196671626000008/xslF345X05/form4-03242026_080316.xml ...
LSI Industries Completes Acquisition of Royston Group
LSI Industries Completes Acquisition of Royston Group
Mar 24, 2026
Transaction Creates Leading Integrated Retail Branding Solutions Platform CINCINNATI--(BUSINESS WIRE)-- LSI Industries Inc. ( LYTS ) a leading U.S. based manufacturer of commercial lighting and display solutions, today announced it has completed the acquisition of Royston Group (“Royston”), a leader in identity and equipment solutions for retail environments, from Industrial Opportunity Partners (“IOP”), following the satisfaction of customary closing...
Velo3D Q4 Adjusted Loss Narrows, Revenue Falls
Velo3D Q4 Adjusted Loss Narrows, Revenue Falls
Mar 24, 2026
04:28 PM EDT, 03/24/2026 (MT Newswires) -- Velo3D ( VELO ) reported a Q4 adjusted loss late Tuesday of $0.54 per diluted share, narrowing from the loss of $8.71 a year earlier. Two analysts polled by FactSet expected a loss of $0.56. Revenue in the three months ended Dec. 31 fell to $9.44 million from $12.6 million a year earlier....
Braze Fiscal Q4 Adjusted Earnings Decline, Revenue Climbs; Shares Jump After Hours
Braze Fiscal Q4 Adjusted Earnings Decline, Revenue Climbs; Shares Jump After Hours
Mar 24, 2026
04:27 PM EDT, 03/24/2026 (MT Newswires) -- Braze (BRZE) reported fiscal Q4 non-GAAP net income late Tuesday of $0.10 per diluted share, down from $0.12 a year earlier. Analysts polled by FactSet expected $0.14. Revenue for the quarter ended Jan. 31 was $205.2 million, up from $160.4 million a year earlier. Analysts expected $198.2 million. For fiscal Q1, the company...
Copyright 2023-2026 - www.financetom.com All Rights Reserved